Edition:
United Kingdom

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

4.15USD
20 Apr 2018
Change (% chg)

$-0.20 (-4.60%)
Prev Close
$4.35
Open
$4.30
Day's High
$4.30
Day's Low
$4.15
Volume
1,302
Avg. Vol
3,968
52-wk High
$10.05
52-wk Low
$3.20

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.85
Market Cap(Mil.): $55.17
Shares Outstanding(Mil.): 8.69
Dividend: --
Yield (%): --

Financials

  PLXP.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -8.18 -- --
ROI: -54.02 1.58 14.38
ROE: -75.17 2.41 16.07

BRIEF-PLx Pharma Q4 Loss Per Share $0.90

* Q4 REVENUE $340,000 Source text for Eikon: Further company coverage:

23 Mar 2018

BRIEF-Park West Asset Management reports 12.3 pct stake in PLx Pharma

* Park West Asset Management Llc reports 12.3 percent stake in PLx Pharma Inc ‍​as of November 20 - SEC filing

20 Nov 2017

BRIEF-PLx Pharma Inc. Reports third quarter 2017 results

* Q3 loss per share $0.44 Source text for Eikon: Further company coverage:

09 Nov 2017

Earnings vs. Estimates